Matus Studeny
Impact in
- Genetics top 0.5%
- Mesenchymal stem cell research
- Virus-based gene therapy research
- Glioma Diagnosis and Treatment
- Biotechnology top 1%
- Cancer Research and Treatments
Papers in
- Co-authors
- Michael Andreeff (6 shared papers)Frank C. Marini (4 shared papers)Claudia Zompetta (3 shared papers)Richard E. Champlin (2 shared papers)Jennifer Lynn Dembinski (5 shared papers)Isaiah J. Fidler (1 shared paper)Maria da Graça Cabreira-Hansen (1 shared paper)Micheal Andreeff (1 shared paper)
- Journals
- Annals of Oncology (8 papers)JNCI Journal of the National Cancer Institute (2 papers)European Journal of Cancer (2 papers)BMC Cancer (1 paper)Clinical Colorectal Cancer (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Matus Studeny
22 papers receiving 3k citations
Matus Studeny's Hit Papers
Peers
Comparison fields: 5 of 72
- Genetics 1.8k
- Biotechnology 262
- Oncology 548
- Biomaterials 163
- Genetics 342
Countries citing papers authored by Matus Studeny
This map shows the geographic impact of Matus Studeny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matus Studeny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matus Studeny more than expected).
Fields of papers citing papers by Matus Studeny
This network shows the impact of papers produced by Matus Studeny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matus Studeny. The network helps show where Matus Studeny may publish in the future.
Co-authors
The 25 scholars most cited alongside Matus Studeny, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human Bone Marrow–Derived Mesenchymal Stem Cells in the Treatment of Gliomas Hit paper breakdown → | 2005 | 918 |
| 2 | Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. | 2002 | 807 |
| 3 | 2004 | 710 | |
| 4 | 2007 | 150 | |
| 5 | 2013 | 60 | |
| 6 | 2018 | 53 | |
| 7 | 2009 | 51 | |
| 8 | 2013 | 48 | |
| 9 | 2022 | 47 | |
| 10 | 1994 | 37 | |
| 11 | 2015 | 34 | |
| 12 | 2018 | 27 | |
| 13 | 2014 | 24 | |
| 14 | 2015 | 24 | |
| 15 | 2011 | 20 | |
| 16 | 2025 | 16 | |
| 17 | 2024 | 8 | |
| 18 | 2016 | 6 | |
| 19 | 2012 | 4 | |
| 20 | Efficacy and safety of nintedanib vs sorafenib in Asian patients with advanced hepatocellular carcinoma (HCC): A randomised Phase II trial | 2013 | 4 |
About Matus Studeny
Matus Studeny is a scholar working on Oncology, Genetics, Hepatology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 3.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (7 papers), Mesenchymal stem cell research (6 papers), Lung Cancer Research Studies (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Chemotherapy-induced cardiotoxicity and mitigation (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Genetics (1.8k citations), Biotechnology (262 citations), Oncology (548 citations), Biomaterials (163 citations) and Genetics (342 citations). Matus Studeny has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Michael Andreeff, Frank C. Marini, Claudia Zompetta, Richard E. Champlin, Jennifer Lynn Dembinski, Isaiah J. Fidler, Maria da Graça Cabreira-Hansen, Micheal Andreeff, Benjamin Nebiyou Bekele and Frederick F. Lang. Their work appears in journals such as Annals of Oncology, JNCI Journal of the National Cancer Institute, European Journal of Cancer, BMC Cancer and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.